post-add

Novo Nordisk Completes 100 Years Of Service

Novo Nordisk in India marked the company’s 100th global anniversary in a grand event today and reaffirmed its commitment to providing care for people with diabetes, haemophilia, and other chronic diseases through its ’Driving Change for Generations’ campaign. On this occasion, the company launched a digital employee community outreach portal aimed at encouraging employees to volunteer for community service and give back to the society. 

The digital community outreach portal will enable all employees to make significant contributions through their time, efforts, and skills. They will be able to collaborate with non-profit organisations across the nation, virtually or in-person.

While addressing the media, CVP & MD, Novo Nordisk India, Vikrant Shrotriya said, “It is indeed an honour to represent a company that has stood the test of time and stands tall after 100 successful years. Novo Nordisk, as a company, is driven by an undying belief in innovating for better access to healthcare for people living with chronic disorders. We are not only committed to providing better medicines, but are equally invested in modern R&D that goes behind developing these medicines and therapies. GLP-1 RA in oral form launched by Novo Nordisk last year is a testimony to our commitment. Going forward, we will continue our efforts to improving access to better care and supporting the capability development of the Indian healthcare infrastructure for better management of non-communicable diseases.”

“Celebrating 100 years is both humbling and a proud once-in-a-lifetime experience for us at Novo Nordisk. India is a fantastic opportunity for us to combine our scientific know-how with the expertise of tech players to create sustainable digital solutions for people living with chronic disorders. This is a great time for us at Novo Nordisk to leverage this ecosystem of talent and startups to revolutionize healthcare in the country” commented Corporate Vice President and Managing Director, Novo Nordisk Global Business Services, John Dawber. 

Also Read

Subscribe to our newsletter to get updates on our latest news